1. Overcoming Inherent Resistance to Proteasome Inhibitors in Head and Neck Cancer: Challenges and New Approaches
   Jason I. Kass et al, 2014, Resistance to Proteasome Inhibitors in Cancer CrossRef
2. RETRACTED: Effect of PLK1 inhibition on cisplatin‐resistant gastric cancer cells
   Zihao Chen et al, 2019, Journal of Cellular Physiology CrossRef
3. PLK1 inhibition-based combination therapies for cancer management
   Shengqin Su et al, 2022, Translational Oncology CrossRef
4. Inhibition of PLK4 might enhance the anti‐tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway
   Jing Wang et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
5. Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells
   Monica Benvenuto et al, 2021, Scientific Reports CrossRef
6. Mitosis-targeting therapies: a troubleshooting guide
   Elena Doménech et al, 2013, Current Opinion in Pharmacology CrossRef